Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies

Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed tofacitinib efficacy on enthesitis by baseline location and severity, and impact on...

Source: Arthritis Research and Therapy - August 22, 2023 Category: Rheumatology Authors: Philip J. Mease, Ana-Maria Orbai, Oliver FitzGerald, Mohamed Bedaiwi, Dona  L. Fleishaker, Rajiv Mundayat, Pamela Young and Philip S. Helliwell Tags: Research Source Type: research